Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial

Q1 Medicine
Julius Schuster , Christin Mundhenke , Hannah Nordsieck , Camille Pouchieu , Line Pourtau , Andreas Hahn
{"title":"Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial","authors":"Julius Schuster ,&nbsp;Christin Mundhenke ,&nbsp;Hannah Nordsieck ,&nbsp;Camille Pouchieu ,&nbsp;Line Pourtau ,&nbsp;Andreas Hahn","doi":"10.1016/j.sleepx.2025.100147","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>Natural interventions for sleep disturbances, such as saffron extract, are gaining scientific and clinical interest. This 3-arm, randomized, double-blind, placebo-controlled trial examined the effect of a standardized saffron extract (Safr’Inside™) on sleep, stress, and other associated psychological outcomes in 165 adults reporting moderate insomnia.</div></div><div><h3>Methods</h3><div>Participants received 30 mg, 20 mg saffron extract, or placebo for 4 weeks. The primary endpoint was the change in insomnia symptoms (Athens Insomnia Scale, AIS). Secondary outcomes were the Single-Item Sleep Quality Scale (SQS), Perceived Stress Scale (PSS), Patient Health Questionnaire-4 (PHQ-4), Positive and Negative Affect Schedule (PANAS), Epworth Sleepiness Scale (ESS), and World Health Organization Quality of Life (WHOQOL). Analyses followed an intention-to-treat (ITT) approach, with per-protocol (PP) confirmation.</div></div><div><h3>Results</h3><div>Among 150 completers, saffron extract led to a greater reduction in insomnia symptoms (AIS) than the placebo (between-group adjusted mean difference <em>β</em> = −0.95 [95 % CI: −1.79, −0.11], <em>P</em> &lt; .05). In secondary analyses, sleep quality (SQS) improved significantly after 3 weeks and was sustained at week 4 in both saffron groups compared to placebo (30 mg vs placebo: <em>β</em> = 0.82 [95 % CI: 0.22, 1.41], <em>P</em> = .004; 20 mg vs placebo: <em>β</em> = 1.02 [0.43, 1.62], <em>P</em> &lt; .001). Perceived stress (PSS) was significantly reduced with 30 mg or 20 mg saffron extract compared to placebo (30 mg vs placebo: <em>β</em> = −1.87 [95 % CI: −3.23, −0.53], <em>P</em> = .01; 20 mg vs placebo: <em>β</em> = −1.89 [95 % CI: −3.22, −0.52], <em>P</em> = .04). Some improvement in psychological symptoms (PHQ-4) was also observed with 30 mg saffron extract compared to placebo (<em>β</em> = −0.79 [−1.40, −0.18], <em>P</em> = .03). All other measures showed no significant differences. No serious adverse events occurred.</div></div><div><h3>Conclusions</h3><div>Four weeks of 20 or 30 mg saffron extract may reduce insomnia and stress in middle-aged adults. Future research should assess longer interventions and explore which subgroups benefit most from saffron extract.</div></div>","PeriodicalId":37065,"journal":{"name":"Sleep Medicine: X","volume":"10 ","pages":"Article 100147"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep Medicine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590142725000102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

Natural interventions for sleep disturbances, such as saffron extract, are gaining scientific and clinical interest. This 3-arm, randomized, double-blind, placebo-controlled trial examined the effect of a standardized saffron extract (Safr’Inside™) on sleep, stress, and other associated psychological outcomes in 165 adults reporting moderate insomnia.

Methods

Participants received 30 mg, 20 mg saffron extract, or placebo for 4 weeks. The primary endpoint was the change in insomnia symptoms (Athens Insomnia Scale, AIS). Secondary outcomes were the Single-Item Sleep Quality Scale (SQS), Perceived Stress Scale (PSS), Patient Health Questionnaire-4 (PHQ-4), Positive and Negative Affect Schedule (PANAS), Epworth Sleepiness Scale (ESS), and World Health Organization Quality of Life (WHOQOL). Analyses followed an intention-to-treat (ITT) approach, with per-protocol (PP) confirmation.

Results

Among 150 completers, saffron extract led to a greater reduction in insomnia symptoms (AIS) than the placebo (between-group adjusted mean difference β = −0.95 [95 % CI: −1.79, −0.11], P < .05). In secondary analyses, sleep quality (SQS) improved significantly after 3 weeks and was sustained at week 4 in both saffron groups compared to placebo (30 mg vs placebo: β = 0.82 [95 % CI: 0.22, 1.41], P = .004; 20 mg vs placebo: β = 1.02 [0.43, 1.62], P < .001). Perceived stress (PSS) was significantly reduced with 30 mg or 20 mg saffron extract compared to placebo (30 mg vs placebo: β = −1.87 [95 % CI: −3.23, −0.53], P = .01; 20 mg vs placebo: β = −1.89 [95 % CI: −3.22, −0.52], P = .04). Some improvement in psychological symptoms (PHQ-4) was also observed with 30 mg saffron extract compared to placebo (β = −0.79 [−1.40, −0.18], P = .03). All other measures showed no significant differences. No serious adverse events occurred.

Conclusions

Four weeks of 20 or 30 mg saffron extract may reduce insomnia and stress in middle-aged adults. Future research should assess longer interventions and explore which subgroups benefit most from saffron extract.
藏红花提取物对中度失眠症成人睡眠质量的影响:一项分散、随机、双盲、安慰剂对照试验
非自然干预睡眠障碍,如藏红花提取物,正在获得科学和临床的兴趣。这项三组随机、双盲、安慰剂对照试验检测了标准藏红花提取物(Safr 'Inside™)对165名报告中度失眠的成年人的睡眠、压力和其他相关心理结果的影响。方法受试者分别服用30 mg、20 mg藏红花提取物或安慰剂,疗程4周。主要终点是失眠症状的改变(雅典失眠量表,AIS)。次要结果为单项睡眠质量量表(SQS)、感知压力量表(PSS)、患者健康问卷-4 (PHQ-4)、积极和消极影响量表(PANAS)、Epworth嗜睡量表(ESS)和世界卫生组织生活质量量表(WHOQOL)。分析采用意向治疗(ITT)方法,并对每个方案(PP)进行确认。结果在150名完成者中,藏红花提取物比安慰剂更能减轻失眠症状(组间校正平均差β = - 0.95 [95% CI: - 1.79, - 0.11], P <;. 05)。在二次分析中,与安慰剂组相比,两组藏红花组的睡眠质量(SQS)在3周后显著改善,并持续到第4周(30 mg vs安慰剂:β = 0.82 [95% CI: 0.22, 1.41], P = 0.004;20 mg vs安慰剂:β = 1.02 [0.43, 1.62], P <;措施)。与安慰剂相比,30 mg或20 mg藏红花提取物显著降低了感知压力(PSS) (30 mg vs安慰剂:β =−1.87 [95% CI:−3.23,−0.53],P = 0.01;20毫克vs安慰剂:β=−1.89(95%置信区间CI:−3.22−0.52),P = .04点)。与安慰剂相比,30 mg藏红花提取物对心理症状(PHQ-4)也有一定改善(β = - 0.79 [- 1.40, - 0.18], P = .03)。其他指标均无显著差异。未发生严重不良事件。结论4周服用20或30毫克藏红花提取物可减轻中年人的失眠和压力。未来的研究应该评估更长时间的干预措施,并探索哪些亚群从藏红花提取物中获益最多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sleep Medicine: X
Sleep Medicine: X Medicine-Medicine (all)
CiteScore
4.00
自引率
0.00%
发文量
17
审稿时长
25 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信